Buscar
Mostrando ítems 1-10 de 271
Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis
(PLoS ONE, 2013)
Background: Antiretroviral therapy (ART) decreases mortality risk in HIV-infected tuberculosis patients, but the
effect of the duration of anti-tuberculosis therapy and timing of anti-tuberculosis therapy initiation in ...
Preventing mental health risks in volunteers in disaster contexts: The case of the Villarrica Volcano eruption, Chile
(Elsevier Ltd, 2019)
© 2018 Chile is a country that is constantly affected by natural disasters. In this article we present the results of a qualitative follow-up study with members of the Chilean Red Cross, who led the evacuation of the Pucón ...
Clinical and color Doppler ultrasound evaluation of polyacrylamide injection in HIV patients with severe facial lipoatrophy secondary to antiretroviral therapy
(Blackwell Publishing Ltd, 2017)
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background/Purpose: Facial lipoatrophy in HIV patients, secondary to antiretroviral therapy (ART) with thymidine analogs, has been related to important ...
CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean
(Oxford University Press, 2015)
We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virusinfected adults from Latin America and the Caribbean. ...
Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America
(Int Aids Society, 2016)
Introduction: Latinos living with HIV in the Americas share a common ethnic and cultural heritage. In North America, Latinos have a relatively high rate of new HIV infections but lower rates of engagement at all stages of ...
Monitoring of HIV treatment in seven countries in the WHO Region of the Americas
(World Health Organization, 2015)
Objective To determine the prevalence of adequate monitoring and the costs of measuring CD4+T-Iymphocytes (CD4+ cell) and human immunodeficiency virus (HIV) viral load in people receiving antiretroviral therapy (ART) in ...
Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
(British HIV Association, 2015)
Objectives
The risks and benefits of initiating antiretroviral treatment (ART) at high CD4 cell counts have
not been reliably quantified. The Strategic Timing of AntiRetroviral Treatment (START) study is a
randomized ...